Novo Nordisk Sues Lilly Over 'Deceptive' GLP-1 Drug Ads
Business4 sources
Novo Nordisk sued Eli Lilly for allegedly running a 'deceptive' ad campaign that uses outdated clinical trials to make its obesity and diabetes drugs appear more effective.[4970884][4979605][4995099][4995681]